chr9-710915-A-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The ENST00000382293.7(KANK1):​c.-326A>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00859 in 1,614,174 control chromosomes in the GnomAD database, including 82 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0060 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0089 ( 76 hom. )

Consequence

KANK1
ENST00000382293.7 5_prime_UTR_premature_start_codon_gain

Scores

7
5
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:6

Conservation

PhyloP100: 8.84

Publications

9 publications found
Variant links:
Genes affected
KANK1 (HGNC:19309): (KN motif and ankyrin repeat domains 1) The protein encoded by this gene belongs to the Kank family of proteins, which contain multiple ankyrin repeat domains. This family member functions in cytoskeleton formation by regulating actin polymerization. This gene is a candidate tumor suppressor for renal cell carcinoma. Mutations in this gene cause cerebral palsy spastic quadriplegic type 2, a central nervous system development disorder. A t(5;9) translocation results in fusion of the platelet-derived growth factor receptor beta gene (PDGFRB) on chromosome 5 with this gene in a myeloproliferative neoplasm featuring severe thrombocythemia. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 20. [provided by RefSeq, Dec 2014]
KANK1 Gene-Disease associations (from GenCC):
  • spastic quadriplegic cerebral palsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • cerebral palsy, spastic quadriplegic, 2
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012142837).
BP6
Variant 9-710915-A-T is Benign according to our data. Variant chr9-710915-A-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 377350.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 6 Unknown,AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KANK1NM_015158.5 linkc.149A>T p.Asp50Val missense_variant Exon 3 of 12 ENST00000382297.7 NP_055973.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KANK1ENST00000382297.7 linkc.149A>T p.Asp50Val missense_variant Exon 3 of 12 1 NM_015158.5 ENSP00000371734.2

Frequencies

GnomAD3 genomes
AF:
0.00597
AC:
908
AN:
152184
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00193
Gnomad AMI
AF:
0.0789
Gnomad AMR
AF:
0.00301
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00969
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00565
AC:
1420
AN:
251486
AF XY:
0.00561
show subpopulations
Gnomad AFR exome
AF:
0.00166
Gnomad AMR exome
AF:
0.00301
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00273
Gnomad NFE exome
AF:
0.00993
Gnomad OTH exome
AF:
0.00668
GnomAD4 exome
AF:
0.00887
AC:
12960
AN:
1461872
Hom.:
76
Cov.:
33
AF XY:
0.00854
AC XY:
6208
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00131
AC:
44
AN:
33480
American (AMR)
AF:
0.00309
AC:
138
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00279
AC:
73
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00191
AC:
165
AN:
86258
European-Finnish (FIN)
AF:
0.00358
AC:
191
AN:
53418
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.0107
AC:
11855
AN:
1111992
Other (OTH)
AF:
0.00806
AC:
487
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
694
1389
2083
2778
3472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00596
AC:
907
AN:
152302
Hom.:
6
Cov.:
32
AF XY:
0.00507
AC XY:
378
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00193
AC:
80
AN:
41558
American (AMR)
AF:
0.00301
AC:
46
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4832
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00967
AC:
658
AN:
68026
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
51
102
153
204
255
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00709
Hom.:
6
Bravo
AF:
0.00634
TwinsUK
AF:
0.00809
AC:
30
ALSPAC
AF:
0.0112
AC:
43
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.00977
AC:
84
ExAC
AF:
0.00607
AC:
737
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00878
EpiControl
AF:
0.00723

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 28, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KANK1: BS1 -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Amyotrophic lateral sclerosis Uncertain:1
-
UM ALS/MND Lab, University Of Malta
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
May 30, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.56
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.39
T;T;T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.82
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
.;D;.
M_CAP
Benign
0.053
D
MetaRNN
Benign
0.012
T;T;T
MetaSVM
Benign
-0.50
T
MutationAssessor
Benign
2.0
M;M;M
PhyloP100
8.8
PrimateAI
Uncertain
0.71
T
PROVEAN
Pathogenic
-6.6
D;.;D
REVEL
Uncertain
0.54
Sift
Pathogenic
0.0
D;.;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
0.99
D;D;D
Vest4
0.77
MVP
0.71
ClinPred
0.027
T
GERP RS
6.0
Varity_R
0.94
gMVP
0.34
Mutation Taster
=284/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61737971; hg19: chr9-710915; COSMIC: COSV63212695; API